Skip to content
value.today

Dynova Laboratories Inc

Total raised
$15 M
1 round on record
Latest round
$15 M
Apr 2007
First round on record
Apr 2007
Today
Private
No later event on record

Funding rounds

1 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Dynova Laboratories Inc
MonthRaisedRaiseSizeInvestorsSoldFiling
Apr 2007$15 MNo. 1$10 to $50 million

Dynova Laboratories Inc: Raise no. 1, Apr 2007

Investors in this round

2 investors had bought by the notice of Dec 4, 2009: 2 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$15 M of $25 M offered; $10 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • 06
Meant to last
more than a year
Issuer's revenue
$1 million to $5 million
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Andrew Schiff, MD · Executive Officer, Director
  • Anthony Y. Sun, MD · Executive Officer, Director
  • Dennis Y. Purcell · Executive Officer, Director
  • Lynne Y. Millheiser Swanbeck · Executive Officer, Director
  • N/A Aisling Capital · Promoter
  • N/A Menemsha Capital Partners · Promoter

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Lynne Millheiser Swanbeck, Chief Executive Officer. Source: SEC Form D and 1 amendment, newest notice filed Dec 4, 2009. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Dynova Laboratories Inc had revenue between $1 million and $5 million when it filed its newest notice of a funding round (Dec 2009).

    SEC Form D (revenue range) · Dec 2009

  • The industry group it chose in its notices: Other Health Care.

    SEC Form D · Dec 2009

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Dynova Laboratories Inc is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 1 round above had up to 2 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Dynova Laboratories Inc
NameRoleNamed in
Andrew Schiff, MDExecutive officerDec 2009
Anthony Y. Sun, MDExecutive officerDec 2009
Dennis Y. PurcellExecutive officerDec 2009
Lynne Y. Millheiser SwanbeckExecutive officerDec 2009
Dennis PurcellExecutive officerJun 2009
Lynne Millheiser SwanbeckExecutive officerJun 2009
Andrew Schiff, MDDirectorDec 2009
Anthony Y. Sun, MDDirectorDec 2009
Dennis Y. PurcellDirectorDec 2009
Lynne Y. Millheiser SwanbeckDirectorDec 2009
Dennis PurcellDirectorJun 2009
Lynne Millheiser SwanbeckDirectorJun 2009
N/A Aisling CapitalPromoterDec 2009
N/A Menemsha Capital PartnersPromoterDec 2009